AcroCyte Therapeutics
Company

AcroCyte Therapeutics

Biotechnology Research Taipei, Tw 13 employees
Employees
13
Contacts
1
Emails
1

AcroCyte Therapeutics Overview

Headquarters
Taipei, Tw
Industry
Biotechnology Research
Employees
13
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About AcroCyte Therapeutics

AcroCyte Therapeutics Inc. is revolutionizing precision medicine through R3CE® (Rapid, Reproducible, Rare Cell 3D Expansion)—the world's only technology that successfully cultures CTCs (Circulating Tumor Cells) from blood and creates personalized 3D cell cultures from any tissue specimen in a week. Our breakthrough eliminates the need for traditional cell lines and animal testing, empowering patients to access truly personalized treatments using their own cells. Through our Onco-REAL™ clinical service, we're transforming cancer care with precise, patient-specific solutions.

AcroCyte Therapeutics Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

AcroCyte Therapeutics Org Chart

Sample employees and titles
Name Title Contact
John Chen Senior Scientist/director at Acrocyte
View
Yuhua Lee Director of Manufacturing
Email
Yung-Hao Lin Chemical Engineering Phd - Biomaterials
View
Roxanne Chen Corporate Strategy - Business
View

Employees by Management Level

Director 2 profiles
Individual contributor 2 profiles

AcroCyte Therapeutics Tech Stack

Data / AI 1 profile
Engineering 1 profile

Compare Similar Companies to AcroCyte Therapeutics